Northern Right Capital Management’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Northern Right Capital Management’s Portfolio RGDX Stock Details RGDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,030,096	Closed	-$706K	–	24
2014 Q3	$706K	Sell	1,030,096 -217,698	-17%	-$171K	0.39%	21
2014 Q2	$1.15M	Sell	1,247,794 -775,096	-38%	-$811K	0.71%	17
2014 Q1	$2.41M	Sell	2,022,890 -106,151	-5%	-$148K	1.51%	16
2013 Q4	$2.47M	Sell	2,129,041 -221,411	-9%	-$363K	1.29%	12
2013 Q3	$5.22M	Sell	2,350,452 -478,966	-17%	-$967K	3.23%	9
2013 Q2	$4.3M	Buy	+2,829,418	New	+$3.85M	3.1%	8

Other funds holding RGDX

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

LPU

Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Northern Right Capital Management's RGDX Position: Q4 2014 in Review

Northern Right Capital Management sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q4 2014, closing a stake of 1,030,096 shares — an estimated $706K sold.

Northern Right Capital Management first reported a position in RGDX in Q2 2013 and held it in 6 quarters. The position peaked at $5.22M in Q3 2013. 16 funds tracked by Wall St. Rank hold RGDX as of Q4 2014.

Northern Right Capital Management reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q4 2014 after selling out during the quarter.
Northern Right Capital Management sold 1,030,096 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q4 2014, an estimated $706K.
Northern Right Capital Management first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q2 2013 and held it in 6 quarters.
Northern Right Capital Management's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $5.22M in Q3 2013.
16 funds tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q4 2014.

Based on Northern Right Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.